Home » Topics » Regulatory

Regulatory
RSS

Rozerem receives FDA approval for insomnia

July 26, 2005

Retisert launched for chronic noninfectious uveitis

July 6, 2005

New approval for Topamax

July 5, 2005

Avelox approved for complicated skin and skin structure infections

July 1, 2005

BiDil approved for treatment of heart failure in black patients

June 28, 2005

Accelerated approval for Aptivus in HIV

June 23, 2005

Tygacil receives FDA approval

June 17, 2005

Enbrel approved to improve physical function in psoriatic arthritis

June 2, 2005

FDA approval for Naglazyme

June 2, 2005

New approval for Arixtra

May 31, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...